A Pharmacokinetic Study Of The Combined Use Of Recombinant Human GH And IGF-1 In Children With Inflammatory Bowel (Crohn's) Disease.

Trial Profile

A Pharmacokinetic Study Of The Combined Use Of Recombinant Human GH And IGF-1 In Children With Inflammatory Bowel (Crohn's) Disease.

Suspended
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Mecasermin (Primary) ; Somatropin (Primary)
  • Indications Short stature
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 04 Dec 2013 Status changed from recruiting to suspended as reported by United Kingdom Clinical Research Network record.
    • 07 Apr 2013 Accrual to date is 16% according to United Kingdom Clinical Research Network.
    • 07 Mar 2013 Accrual to date is 12% according to United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top